Tumor-targeted nanosystem with hypoxia inducible factor 1α inhibition for synergistic chemo-photodynamic therapy against hypoxic tumor
- 13 December 2024
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 248, 114456
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondriaAnalytica Chimica Acta, 2024
- Controllable Regulation of Ag2S Quantum‐Dot‐Mediated Protein Nanoassemblies for Imaging‐Guided Synergistic PDT/PTT/Chemotherapy against Hypoxic TumorAdvanced Healthcare Materials, 2023
- Toad venom bufadienolides and bufotoxins: An updated reviewDrug Development Research, 2023
- Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancerActa Pharmaceutica Sinica B, 2022
- Conquering the Hypoxia Limitation for Photodynamic TherapyAdvanced Materials, 2021
- Hypoxia-mediated drug resistance in breast cancersCancer Letters, 2021
- Biomimetic Liposomal Nanoplatinum for Targeted Cancer ChemophototherapyAdvanced Science, 2021
- Polydopamine‐Based Nanoparticles for Photothermal Therapy/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor TreatmentThe Chemical Record, 2021
- Photodynamic therapy with smart nanomedicineArchives of Pharmacal Research, 2020
- Multifunctional hyaluronic acid-mediated quantum dots for targeted intracellular protein delivery and real-time fluorescence imagingCarbohydrate Polymers, 2019